OBJECTIVE: To compare long term recurrence of cancer and survival of patients having major abdominal surgery for cancer. DESIGN: Long term follow-up of prospective randomised controlled clinical trial in which patients were randomly assigned to receive general anaesthesia with or without epidural block for at least three postoperative days. Setting 23 hospitals in Australia, New Zealand, and Asia. PARTICIPANTS: 503 adult patients who had potentially curative surgery for cancer. MAIN OUTCOME MEASURE: Cancer-free survival (analysis was by intention to treat). RESULTS: Long term follow-up data were available for 94% (n=446) of eligible participants. The median time to recurrence of cancer or death was 2.8 (95% confidence interval 0.7 to 8.7) years in the control group and 2.6 (0.7 to 8.7) years in the epidural group (P=0.61). Recurrence-free survival was similar in both epidural and control groups (hazard ratio 0.95, 95% confidence interval 0.76 to 1.17; P=0.61). CONCLUSION: Use of epidural block in abdominal surgery for cancer is not associated with improved cancer-free survival. TRIAL REGISTRATION: Australian New Zealand Clinical Trials Registry ACTRN12607000637448.
RCT Entities:
OBJECTIVE: To compare long term recurrence of cancer and survival of patients having major abdominal surgery for cancer. DESIGN: Long term follow-up of prospective randomised controlled clinical trial in which patients were randomly assigned to receive general anaesthesia with or without epidural block for at least three postoperative days. Setting 23 hospitals in Australia, New Zealand, and Asia. PARTICIPANTS: 503 adult patients who had potentially curative surgery for cancer. MAIN OUTCOME MEASURE: Cancer-free survival (analysis was by intention to treat). RESULTS: Long term follow-up data were available for 94% (n=446) of eligible participants. The median time to recurrence of cancer or death was 2.8 (95% confidence interval 0.7 to 8.7) years in the control group and 2.6 (0.7 to 8.7) years in the epidural group (P=0.61). Recurrence-free survival was similar in both epidural and control groups (hazard ratio 0.95, 95% confidence interval 0.76 to 1.17; P=0.61). CONCLUSION: Use of epidural block in abdominal surgery for cancer is not associated with improved cancer-free survival. TRIAL REGISTRATION: Australian New Zealand Clinical Trials Registry ACTRN12607000637448.
Authors: Kenneth C Cummings; Meatal Patel; Phyo Than Htoo; Paul M Bakaki; Linda C Cummings; Siran Koroukian Journal: Reg Anesth Pain Med Date: 2014 May-Jun Impact factor: 6.288
Authors: Elena F Wurster; Frank Pianka; Rene Warschkow; Pia Antony; Thorsten Brenner; Markus A Weigand; Bruno M Schmied; Markus W Büchler; Ignazio Tarantino; Alexis Ulrich Journal: Int J Colorectal Dis Date: 2019-06-06 Impact factor: 2.571
Authors: Andrew J Page; Aslam Ejaz; Gaya Spolverato; Tiffany Zavadsky; Michael C Grant; Daniel J Galante; Elizabeth C Wick; Matthew Weiss; Martin A Makary; Christopher L Wu; Timothy M Pawlik Journal: J Gastrointest Surg Date: 2014-12-04 Impact factor: 3.452
Authors: F J Vogelaar; R Abegg; J C van der Linden; H G J M Cornelisse; F R C van Dorsten; V E Lemmens; K Bosscha Journal: Int J Colorectal Dis Date: 2015-04-28 Impact factor: 2.571